Open AccessTHE ANTI-TUBERCULOSIS ANTIBIOTIC OF RIFAPENTINE: PERSPECTIVES OF CLINICAL USE
Author(s) -
Anastasia Samoilova,
Elena Veselova,
Olga Lovacheva,
G Kaminskiy
Publication year - 2019
Publication title -
tuberkulez i bolezni lëgkih/tuberkulëz i bolezni lëgkih
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.226
H-Index - 12
eISSN - 2542-1506
pISSN - 2075-1230
DOI - 10.21292/2075-1230-2018-96-12-55-61
Subject(s) - rifapentine , tolerability , medicine , tuberculosis , latent tuberculosis , adverse effect , mycobacterium tuberculosis , chemotherapy , antibiotics , drug , human immunodeficiency virus (hiv) , pharmacotherapy , intensive care medicine , immunology , pharmacology , pathology , microbiology and biotechnology , biology